MedPath

浙江百代医药科技有限公司

Ownership
-
Established
2018-12-18
Employees
-
Market Cap
-
Website
www.bio-dia.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Indobufen Tablets

Product Name
吲哚布芬片
Approval Number
国药准字H20253943
Approval Date
Apr 15, 2025
NMPA

Metoclopramide Hydrochloride Injection

Product Name
盐酸甲氧氯普胺注射液
Approval Number
国药准字H20249243
Approval Date
Nov 5, 2024
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20244724
Approval Date
Aug 27, 2024
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20244749
Approval Date
Aug 27, 2024
NMPA

Aripiprazole Oral Solution

Product Name
阿立哌唑口服溶液
Approval Number
国药准字H20243301
Approval Date
Jul 23, 2024
NMPA

Aripiprazole Oral Solution

Product Name
阿立哌唑口服溶液
Approval Number
国药准字H20243299
Approval Date
Jul 23, 2024
NMPA

Aripiprazole Oral Solution

Product Name
阿立哌唑口服溶液
Approval Number
国药准字H20243298
Approval Date
Jul 23, 2024
NMPA

Aripiprazole Oral Solution

Product Name
阿立哌唑口服溶液
Approval Number
国药准字H20243300
Approval Date
Jul 23, 2024
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20244227
Approval Date
Jun 28, 2024
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20244228
Approval Date
Jun 28, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy